Occlusion - renal artery and Nephrogenic systemic fibrosis - from FDA reports

Summary

Nephrogenic systemic fibrosis is found among people with Occlusion - renal artery, especially for people who are male, 60+ old, take medication Omniscan and have High blood pressure. This review analyzes which people have Nephrogenic systemic fibrosis with Occlusion - renal artery. It is created by eHealthMe based on reports of 63 people who have Occlusion - renal artery from FDA , and is updated regularly.

What to expect?

If you have Occlusion - renal artery and Nephrogenic systemic fibrosis, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 14, 2017

63 people who have Occlusion - Renal Artery and Nephrogenic Systemic Fibrosis are studied.


Number of reports submitted per year:

Would you have Nephrogenic systemic fibrosis when you have Occlusion - renal artery?

Gender of people who have Occlusion - Renal Artery and experience Nephrogenic Systemic Fibrosis *:

  • female: 46.03 %
  • male: 53.97 %

Age of people who have Occlusion - Renal Artery and experience Nephrogenic Systemic Fibrosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.08 %
  • 40-49: 14.58 %
  • 50-59: 22.92 %
  • 60+: 60.42 %

Top co-existing conditions for these people *:

  • High Blood Pressure (11 people, 17.46%)
  • Renal Failure Chronic (10 people, 15.87%)
  • Nuclear Magnetic Resonance Imaging Abdominal (8 people, 12.70%)
  • Cardiac Failure Congestive (8 people, 12.70%)
  • Angioplasty (8 people, 12.70%)

Most common drugs for these people *:

  • Omniscan (59 people, 93.65%)
  • Magnevist (28 people, 44.44%)
  • Prohance (14 people, 22.22%)
  • Neurontin (13 people, 20.63%)
  • Plavix (10 people, 15.87%)

Top symptoms for these people *:

  • Normochromic Normocytic Anaemia (3 people, 4.76%)
  • Pseudomonas Infection (2 people, 3.17%)
  • Lung Infection (2 people, 3.17%)
  • Dialysis (2 people, 3.17%)
  • Chronic Obstructive Pulmonary Disease (2 people, 3.17%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Nephrogenic systemic fibrosis and Occlusion - renal artery?

Expand the study to include reports from both FDA and eHealthMe

Nephrogenic systemic fibrosis and Occlusion - renal artery from FDA and eHealthMe reports

Occlusion - Renal Artery

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) (latest reports from 1,802 Occlusion - renal artery patients)

Nephrogenic Systemic Fibrosis

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease) has been reported by people with nuclear magnetic resonance imaging abnormal, arteriogram, nuclear magnetic resonance imaging brain, nuclear magnetic resonance imaging abdominal abnormal, nuclear magnetic resonance imaging abdominal (latest reports from 6,007 Nephrogenic systemic fibrosis patients).

Browse all symptoms of Occlusion - renal artery

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Nephrogenic systemic fibrosis

Nephrogenic systemic fibrosis

Other conditions that could case Nephrogenic systemic fibrosis

Nephrogenic systemic fibrosis

Related studies

What would happen?

Forecast new side effects and undetected conditions when you have Occlusion - renal artery and Nephrogenic systemic fibrosis.